Allogeneic Stem Cell Transplantation as Treatment for Myelofibrosis

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1705516
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Janus Kinase Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Serial 18f-FDG PET for Monitoring Treatment Response After Allogeneic Stem Cell Transplantation for Myelofibrosis

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Diagnostic Value of 18f-FDG-Pet/Ct for Monitoring Myelofibrosis After Allogeneic Stem Cell Transplantation

Nuclear Medicine Review
MedicineNuclear MedicineRadiologyImaging
2015English

Quality of Life Following Allogeneic Stem Cell Transplant for Myelofibrosis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Allogeneic Stem Cell Transplantation for Sickle Cell Disease

Current Opinion in Hematology
Hematology
2016English

Cytokine Expression Pattern in Bone Marrow Microenvironment After Allogeneic Stem Cell Transplantation in Primary Myelofibrosis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Allogeneic Hematopoietic Stem Cell Transplantation

Archives of Internal Medicine
2002English

Second Allogeneic Hematopoietic Stem Cell Transplantation as Treatment for Leukemia Relapsing Following a First Transplant

Bone Marrow Transplantation
TransplantationHematology
2000English

Allogeneic Stem Cell Transplantation for Korean PNH Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy